You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Independent Validation of Effect of HSD3B1 Genotype on Response to Androgen-Deprivation Therapy in Prostate Cancer
|
---|---|
Published in |
JAMA Oncology, June 2017
|
DOI | 10.1001/jamaoncol.2017.0147 |
Pubmed ID | |
Authors |
Neeraj Agarwal, Andrew W. Hahn, David M. Gill, James M. Farnham, Austin I. Poole, Lisa Cannon-Albright |
X Demographics
The data shown below were collected from the profiles of 46 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 20 | 43% |
Spain | 8 | 17% |
United Kingdom | 2 | 4% |
Ecuador | 1 | 2% |
Australia | 1 | 2% |
Brazil | 1 | 2% |
Venezuela, Bolivarian Republic of | 1 | 2% |
Argentina | 1 | 2% |
Unknown | 11 | 24% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 27 | 59% |
Practitioners (doctors, other healthcare professionals) | 9 | 20% |
Scientists | 8 | 17% |
Science communicators (journalists, bloggers, editors) | 2 | 4% |
Mendeley readers
The data shown below were compiled from readership statistics for 28 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 28 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Other | 5 | 18% |
Student > Doctoral Student | 3 | 11% |
Researcher | 3 | 11% |
Student > Bachelor | 2 | 7% |
Student > Master | 2 | 7% |
Other | 4 | 14% |
Unknown | 9 | 32% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 8 | 29% |
Biochemistry, Genetics and Molecular Biology | 3 | 11% |
Agricultural and Biological Sciences | 1 | 4% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 4% |
Computer Science | 1 | 4% |
Other | 1 | 4% |
Unknown | 13 | 46% |
Attention Score in Context
This research output has an Altmetric Attention Score of 37. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 May 2020.
All research outputs
#1,110,857
of 25,692,343 outputs
Outputs from JAMA Oncology
#1,567
of 3,345 outputs
Outputs of similar age
#22,006
of 331,513 outputs
Outputs of similar age from JAMA Oncology
#49
of 84 outputs
Altmetric has tracked 25,692,343 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,345 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 84.2. This one has gotten more attention than average, scoring higher than 53% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 331,513 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 84 others from the same source and published within six weeks on either side of this one. This one is in the 41st percentile – i.e., 41% of its contemporaries scored the same or lower than it.